Doug Kass shares his views on Potash, Radian and oil, and revisits his prediction about KaloBios.
As Wall Street prepares to close out 2015 much where it started, investors looked to the year ahead to determine direction on the second-last day of trading.
Stocks move slightly lower as another selloff in crude oil prices hits the energy sector.
KaloBios Pharmaceuticals has filed for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court.
KaloBios Pharmaceuticals (KBIO), the drugmaker that fired CEO Martin Shkreli less than two weeks ago, filed for Chapter 11 bankruptcy on Tuesday.